INNOVATIONS IN AL AMYLOIDOSIS MANAGEMENT
Introduction: Immunoglobulin light chain (AL) amyloidosis is the most common type of systemic amyloidosis. AL amyloidosis is considered a plasma cell disorder caused by generally small and slowly proliferating clone of plasma cells in bone marrow that produces nonfunctional immunoglobulins. Diagnosi...
Saved in:
| Main Author: | Hande Oğul Sücüllü |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Hematology, Transfusion and Cell Therapy |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137924029298 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Localized AL amyloidosis
by: Nelly A. Kashchavtseva, et al.
Published: (2025-01-01) -
Systemic AL Amyloidosis and Precision Medicine
by: Axel Rüfer, et al.
Published: (2021-06-01) -
AL Amyloidosis: Current Treatment and Outcomes
by: Margaret Locke, et al.
Published: (2025-01-01) -
Difficulties in diagnosis of primary AL-amyloidosis
by: V. A. Khyshova, et al.
Published: (2021-09-01) -
Promising Findings in Myeloproliferative Neoplasms and AL Amyloidosis
by: Axel Rüfer
Published: (2022-10-01)